StockNews.AI
BLCO
StockNews.AI
54 days

BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is Investigating Bausch + Lomb Corporation on Behalf of Bausch & Lomb Stockholders and Encourages Investors to Contact the Firm

1. Bragar Eagel & Squire investigates potential securities claims against Bausch + Lomb. 2. A voluntary lens recall triggered a significant stock price drop of 10.6%. 3. Short-term concerns may arise regarding product safety and regulatory scrutiny. 4. Investors may have claims due to alleged unlawful business practices. 5. Legal investigations may further impact Bausch & Lomb's market perception.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The stock has already seen a sharp decline due to recalls, indicating ongoing investor distrust. Historical comparisons show that product recalls often lead to sustained sell-offs.

How important is it?

The ongoing legal investigation and recent recall significantly impact investor confidence and stock value.

Why Short Term?

Legal investigations and product safety issues often affect near-term stock performance, as seen with other companies post-recall.

Related Companies

Bausch + Lomb Corporation (BLCO)Johnson & Johnson (JNJ)AbbVie Inc. (ABBV)
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Bausch + Lomb Corporation (“Bausch & Lomb” or the “Company”) (NYSE:BLCO) on behalf of Bausch & Lomb stockholders. Our investigation concerns whether Bausch & Lomb has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On March 27, 2025, Bausch & Lomb announced a voluntary recall of intraocular lenses on its enVista platform due to reports of toxic anterior segment syndrome (TASS), a potential complication in cataract surgery. The recall may raise short-term concerns about product safety and regulatory scrutiny. Following this news, Bausch & Lomb's stock price dropped $1.50 per share, or 10.6%, to close at $15.00 that same day. If you purchased or otherwise acquired Bausch & Lomb shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News